Literature DB >> 7241957

Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy.

W R Kiessling, R Beckmann.   

Abstract

Using a sensitive myoglobin-radioimmunoassay (Mb-RIA) serum Mb was measured in 50 patients with Duchenne muscular dystrophy (DMD) and compared with the serum creatine kinase (CK) activities. The Mb concentrations (normal range 4-60 ng/ml) measured ranged between 160-6,000 ng/ml and did not only show a significant correlation to the CK but also an inverse relationship to the age of the patients. It is suggested that Mb is an essential adjunct in the diagnosis of DMD.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241957     DOI: 10.1007/bf01525003

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

Review 1.  THE MUSCULAR DYSTROPHIES.

Authors:  W S ZUNDEL; F H TYLER
Journal:  N Engl J Med       Date:  1965-09-02       Impact factor: 91.245

2.  Serum myoglobin level as diagnostic test in patients with acute myocardial infarction.

Authors:  M J Stone; M R Waterman; D Harimoto; G Murray; N Willson; M R Platt; G Blomqvist; J T Willerson
Journal:  Br Heart J       Date:  1977-04

3.  Myoglobinemia following acute myocardial infarction.

Authors:  L Kagen; S Scheidt; L Roberts; A Porter; H Paul
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

4.  Serum myoglobin in primary and secondary skeletal muscle disorders.

Authors:  W R Kiessling; K Ricker; K W Pflughaupt; H G Mertens; I Haubitz
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

5.  Serum myoglobin in myocardial infarction: the "staccato phenomenon." Is acute myocardial infarction in man an intermittent event?

Authors:  L Kagen; S Scheidt; A Butt
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

6.  Serum myoglobin in muscular dystrophy.

Authors:  L J Kagen; S Moussavi; S L Miller; P Tsairis
Journal:  Muscle Nerve       Date:  1980 May-Jun       Impact factor: 3.217

7.  Radioimmunoassay for human myoglobin: methods and results in patients with skeletal muscle or myocardial disorders.

Authors:  K Miyoshi; S Saito; H Kawai; A Kondo; M Iwasa; T Hayashi; M Yagita
Journal:  J Lab Clin Med       Date:  1978-09

8.  Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection.

Authors:  B T Adornato; L J Kagen; W K Engel
Journal:  Lancet       Date:  1978-09-02       Impact factor: 79.321

9.  Myoglobin concentrations and muscle-enzyme activities in serum after myocardial infarction and cardiac arrhythmia.

Authors:  T G Rosano; L A Sanders; E S Johnson; M A Kenny; K J Clayson; P E Strandjord
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

10.  The significance of the estimation of serum myoglobin in neuromuscular diseases.

Authors:  E A Hische; H J van der Helm
Journal:  J Neurol Sci       Date:  1979-10       Impact factor: 3.181

  10 in total
  2 in total

1.  [Myoglobin radioimmunoassay: experience of the diagnosis of skeletal muscle disorders (author's transl)].

Authors:  W R Kiessling; K W Pflughaupt
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

Review 2.  Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics.

Authors:  Carlos D Vera; Angela Zhang; Paul D Pang; Joseph C Wu
Journal:  Front Cardiovasc Med       Date:  2022-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.